Advances in Small Molecule Drug Development Boston 2026

Join us on February 11th 2026 at the Cambridge Innovation Centre, Boston, for a one-day meeting focused on the latest advances in small molecule drug development, exploring the discovery, synthesis, and delivery of novel small molecule therapeutics and conjugates.

The event encourages open discussion between academia, biotech, and pharma to share knowledge and strengthen collaboration across the development pipeline.

Key topics include:

• Novel chemistry-enabled modalities and conjugates
• Scalable synthesis and process development
• Digital, data, and automation in chemical design
• Analytical science and in-process control
• Future trends in small molecule R&D

Featured Speakers

We currently have speakers confirmed from the following organisations:

• Pfizer
• Merck
• Biogen
• Kymera
• Cornell University

Badge Registration Form

Coming soon

Who Should Attend

This conference is for scientists, researchers, and industry professionals involved in the discovery, development, and manufacture of small molecules and conjugates. It offers an opportunity to share experiences, learn from peers, and build connections across different parts of the development journey.

Who should attend:

• Senior leaders in biotech and pharma
• Discovery and process chemists
• Analytical scientists and formulation specialists
• Digital, data, and automation experts
• Academic researchers and group leaders

Join us to explore how science, technology, and interdisciplinary collaboration are reshaping the future of drug development.

Date, Location and Venue

11th February 2026

CIC Boston

50 Milk Street,

Boston, MA 02109

Sponsors and Partners

Please contact Dan Croucher (dan.croucher@catsci.com) for sponsorship information.

Organising Committee

Dan Croucher: dan.croucher@catsci.com

Carlos Cote: carlos.cote@catsci.com

Stay informed on LinkedIn